CervoMed names William Elder as CFO; William Tanner departs to consulting role
CervoMed Inc.
William Elder appointed CFO effective June 1, 2024, succeeding William Tanner; Elder continues as General Counsel and Corporate Secretary.
Outgoing CFO William Tanner to serve as consultant through Dec 2025; receives $162,000 severance plus prorated bonus and extended stock option vesting.
Elder's compensation: base salary $429,000, target bonus 35% of base; severance includes 9 months salary on non-cause termination.
Company expects RewinD-LB Phase 2b enrollment completion in Q2 2024, topline efficacy results in Q4 2024.
appointed William Elder, the Company’s current General Counsel, Corporate Secretary and Acting Principal Financial Officer, to serve as the Company’s Chief Financial Officer, effective June 1, 2024.
Dr. Tanner’s employment with the Company will terminate effective May 31, 2024, and, effective June 1, 2024, Dr. Tanner will begin service as a consultant to the Company.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
William Elder was appointed as Chief Financial Officer at CervoMed Inc..
Action
appointed
Role
Chief Financial Officer
Exact text from the filing
appointed William Elder, the Company’s current General Counsel, Corporate Secretary and Acting Principal Financial Officer, to serve as the Company’s Chief Financial Officer, effective June 1, 2024.
William Tanner was terminated as Chief Financial Officer at CervoMed Inc..
Action
terminated
Role
Chief Financial Officer
Exact text from the filing
Dr. Tanner’s employment with the Company will terminate effective May 31, 2024, and, effective June 1, 2024, Dr. Tanner will begin service as a consultant to the Company.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.